Tag: drug pricing
Make drug price cuts visible: Biden-era law delivers savings for 15...
A new round of Medicare drug price negotiations shows the impact of the Inflation Reduction Act while exposing an ongoing political fight over who deserves credit for lowering drug costs.
Drug prices soar under Trump despite promises, Senate report finds
Senate HELP Minority report says 688 drug prices rose after Trump took office, with some cancer therapies now over $200,000 a year and a rare-disease drug jumping 1,555 percent; White House tariffs and the One Big Beautiful Bill Act could push costs higher still.
Trump’s pharma tariffs set to hit branded drugs as exemptions widen...
Analysts warn of price risks even as generics, U.S. facilities, and European caps could blunt the impact.
Trump’s executive order on drug prices lacks enforcement, legal backing, and...
The president’s directive to lower prescription costs relies on voluntary compliance and vague rulemaking powers, leaving analysts and advocates questioning its efficacy.
Trump executive order hands Big Pharma a major win by delaying...
Order pushes for four-year delay in Medicare price talks for most prescription drugs, echoing pharma lobby demands and risking higher costs for patients.
Breathing relief: AstraZeneca joins movement to cap US inhaler costs amid...
Following Boehringer Ingelheim's lead, AstraZeneca pledges affordable respiratory care in the U.S., sparking calls for industry-wide reform.
Pharma CEOs grilled by Sanders: A standoff on drug pricing
"In a fiery Senate showdown, Senator Bernie Sanders challenges Big Pharma on exorbitant U.S. drug prices, revealing the stark divide between profit margins and patient access to essential medications."
Big Pharma’s battle against FDA-approved medicine imports from Canada
Florida's groundbreaking move: importing affordable medication from Canada. Big Pharma's pushback and the FDA's historic approval — a turning point in U.S. healthcare?
‘What the hell is wrong with them’: GOP senators kill $35...
'Republicans told millions of Americans who use insulin to go to hell.'
‘Is it better than nothing? I suppose’: Sanders disappointed by Dems’...
"It's a very weak proposal" but "we're dealing with the power of PhRMA over the Congress," he said, taking aim at industry lobbyists.













